Related Experiment Video
Updated: Jun 16, 2026

Author Spotlight: Development of a Method for Identifying Small Molecular Antagonists of β2 Integrin Activation
Published on: February 2, 2024
SARS-CoV-2 Immune Complex-Mediated Neutrophil Activation.
Kiana C Allen1,2, Seth Warner1,2, Heather L Teague1,2
1Critical Care Medicine Department, National Institutes of Health Clinical Center, Bethesda, Maryland, USA.
COVID-19 severity is linked to SARS-CoV-2 antibody levels and neutrophil activation. Antigen-antibody complexes, particularly IgA, drive NETosis, a process that can be inhibited by spleen tyrosine kinase blockers.
Area of Science:
- Immunology
- Virology
- Critical Care Medicine
Background:
- Understanding critical illness pathogenesis is key for developing therapies.
- COVID-19, caused by SARS-CoV-2, presents a significant global health challenge requiring deeper insights into its mechanisms.
Purpose of the Study:
- To investigate the association between SARS-CoV-2-specific antibody levels, neutrophil activation, and COVID-19 disease severity.
- To explore the link between adaptive and innate immune responses in severe COVID-19.
- To elucidate the role of SARS-CoV-2 immune complexes in neutrophil extracellular trap formation (NETosis).
Main Methods:
- Analysis of SARS-CoV-2-specific antibody levels and neutrophil activation markers in hospitalized COVID-19 patients.
- In vitro assays to assess the capacity of SARS-CoV-2 antigen-antibody immune complexes to stimulate NETosis.
- Evaluation of the differential roles of IgA and IgG immune complexes in NETosis.
- Assessment of spleen tyrosine kinase inhibition on NETosis.
Main Results:
- Higher SARS-CoV-2-specific antibody levels and neutrophil activation markers correlate with increased COVID-19 disease severity.
- A significant association exists between antibody levels and markers of neutrophil degranulation and NETosis.
- SARS-CoV-2 antigen-antibody immune complexes directly stimulate NETosis in vitro.
- IgA immune complexes show a stronger association with NETosis compared to IgG complexes.
- Spleen tyrosine kinase inhibition effectively ameliorates SARS-CoV-2-induced NETosis.
Conclusions:
- SARS-CoV-2-specific antibodies and neutrophil activation are key indicators of disease severity in hospitalized patients.
- The adaptive immune response, via antibody-immune complexes, directly influences innate immune cell behavior, specifically promoting NETosis.
- Targeting spleen tyrosine kinase may offer a therapeutic strategy to mitigate detrimental NETosis in severe COVID-19.
More Related Videos
07:18Quantifying Myeloperoxidase-DNA and Neutrophil Elastase-DNA Complexes from Neutrophil Extracellular Traps by Using a Modified Sandwich ELISA
Published on: May 12, 2023
11:32Real-Time, High-Throughput Microscopic Quantification of Human Neutrophil Extracellular Trap Release and Assessing the Pharmacology of Antagonists
Published on: October 18, 2024
Related Concept Videos
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Coronavirus
Respiratory Syncytial Virus Disease
Hypersensitivity Reactions: Immune-Complex Reactions